tailieunhanh - World Gastroenterology Organisation Practice Guidelines: Celiac Disease

Testing after vaccination is recommended for persons (including hemodialysis patients) whose subsequent clinical management depends on knowledge of their immune status. "Testing should be performed 1-2 months after administration of the last dose of the vaccine series by using a method that allows determination of a protective level of anti-HBs (10 mIU/mL)." "Persons found to have anti-HBs levels of | WGO Practice Guidelines Celiac disease 1 World Gastroenterology Organisation Practice Guidelines Celiac Disease Review team Prof. J. Bai chairman Prof. E. Zeballos Prof. M. Fried Prof. . Corazza Prof. D. Schuppan Prof. . Farthing Prof. C. Catassi Prof. L. Greco Prof. H. Cohen Dr. . Krabshuis Professor Zeballos co-chairman of the Celiac Disease Review Team passed away suddenly just as work on this guideline started. The WGO Celiac Disease Team acknowledge his contribution and are greatly saddened by his death. Contents 1 Definitions 2 Key points 3 Epidemiology 4 Pathology natural history and associated conditions 5 Diagnosis of celiac disease 6 Management of celiac disease 7 Screening for celiac disease 8 Useful web sites 9 Guidelines list server and further reading 10 Queries and feedback 1 Definitions Celiac disease is a form of enteropathy affecting the small intestine in genetically predisposed children and adults precipitated by the ingestion of gluten-containing foods. It is also referred to as celiac sprue gluten-sensitive enteropathy and nontropical sprue. Gluten is the storage protein in wheat rye and barley that gives the dough its desired baking properties. World Gastroenterology Organisation 2007 WGO Practice Guidelines Celiac disease 2 2 Key points The prevalence of celiac disease in a healthy adult population varies between roughly one in 100 and one in 300 in most parts of the world. Many patients with celiac disease have minimal symptoms or present atypically. For a diagnosis of celiac disease to be made the patient should have Characteristic histopathologic changes in an intestinal biopsy and Clinical improvement in response to a gluten-free diet Serological tests have a role in Confirming celiac disease Screening for individuals who are at risk or not at risk Identifying patients in whom biopsy might be warranted Investigating patients with an increased risk of the disease Patients with celiac disease should not eat wheat rye or barley.

• Sức khỏe trẻ em
• Systemic Therapy
• Advanced Pancreatic Carcinoma
• Immunotherapy
• Overview
• Bacterial Immunotherapy
• Antitumoral Potential
• Hepatocellular carcinoma
• Systemic therapy for hepatocellular carcinoma
• Adjuvant regimens for HCC
• Sorafenib was first approved
• Prolong survival of the patients
• Barcelona Classification
• Summary of doctoral thesis
• Immune disorders and results of pulse methylprednisolone therapy
• Severe systemic lupus erythematosus
• Target organ damage and activity level
• Pulsed methylprednisolone therapy combined
• BMC Cancer
• Adjuvant temozolomide
• Multimodality therapy approaches
• Systemic treatment
• Radiation therapy
• BMC Pulmonary medicine
• Systemic glucocorticoid therapy
• Plasma metabolome
• Systemic glucocorticoid
• Acute exacerbation
• Chronic obstructive pulmonary disease
• Phase II trial
• Selective internal radiation therapy
• Systemic chemotherapy
• Liver predominant metastases
• Pancreatic adenocarcinoma
• Bladder cancer
• Radical cystectomy
• Perioperative chemotherapy
• Perioperative targeted therapy
• Immune therapy
• Gene therapy
• Human HCC cells
• Modified molecule
• Systemic HCC therapy
• Ewing sarcoma
• Complete remission
• Metastatic disease
• Distant metastasis
• Biliary cancer
• Younger patients
• Prospective trials
• Corticosteroids and steroid therapy
• Steroid therapy
• The manager
• Chronic subdural hematoma
• Clinical considerations
• Systemic autoimmune diseases
• Risk factors
• Intrauterine therapy
• Hormonal therapy
• Metritis in cattle
• Competitive mortality
• Non tumoral death
• Head and neck cancer
• Breast cancer
• Neoadjuvant systemic therapy
• Nodal staging
• Chest CT
• BMC Musculoskeletal Disorders
• Rheumatoid arthritis
• Systemic lupus erythematosus
• Autoimmune disorders
• Osteoporotic fractures
• BMC Anesthesiology
• Local anesthetic systemic toxicity
• Lipid rescue therapy
• Intravenous lipid emulsions
• Several international anesthesia organizations
• Carbon monoxide
• Life threatening
• Systemic hyperbaric oxygen
• CO detoxification
• Severely intoxicated patients
• Prognostic models
• Review and critical appraisal
• Advanced hepatocellular carcinoma
• Liver cancer
• Randomized controlled trial
• Systemic anticancer therapy
• Targeted therapy
• Non standard
• Survival outcomes
• Slow growing neoplasm
• Radiological response
• Pancreatic cancer
• Advanced disease
• Second line therapy Progression free survival
• Overall survival
• Biliary tract cancer
• Combination therapy
• Prior systemic therapies
• Prospective randomized
• Neoadjuvant treatment
• Endocrine therapy
• Treatment response
• Post treatment surgical management